Finance

Beta
Lists
2186:HKG
Luye Pharma Group Ltd
HK$1.89
+0.53%
(+0.0100) 1D
Jun 10, 4:09:06 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2186...
Open
HK$1.88
High
HK$1.92
Low
HK$1.83
Mkt. cap
7.55B
Avg. vol.
28.08M
Volume
29.60M
P/E ratio
11.80
52-wk high
HK$4.49
52-wk low
HK$1.74
EPS
HK$0.16
Shares outstanding
3.27B
No. of employees
5K
Open
HK$1.88
High
HK$1.92
Low
HK$1.83
Mkt. cap
7.55B
Avg. vol.
28.08M
Volume
29.60M
P/E ratio
11.80
52-wk high
HK$4.49
52-wk low
HK$1.74
EPS
HK$0.16
Shares outstanding
3.27B
No. of employees
5K
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to 2186 in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for 2186 in the last 3 months.
Highest
Current HK$1.89
HK$4.34 (+129.63%)
Average
HK$4.31 (+128.06%)
Lowest
HK$4.30 (+127.51%)
News stories
From sources across the web
About Luye Pharma Group Ltd
CEO-
Employees5.22K
Founded1994
Headquarters-
SectorPharmaceutical industry
Websiteluye.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.59B
1.59B
1.56B
1.56B
Cost of goods sold
511.75M
511.75M
561.14M
561.14M
Cost of revenue
511.75M
511.75M
561.14M
561.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
667.15M
667.15M
585.74M
585.74M
Operating expense
773.64M
773.64M
698.83M
698.83M
Total operating expenses
1.29B
1.29B
1.26B
1.26B
Operating income
305.16M
305.16M
303.66M
303.66M
Other non operating income
68.07M
68.07M
-39.49M
-39.49M
EBT including unusual items
228.82M
228.82M
243.50M
243.50M
EBT excluding unusual items
213.42M
213.42M
193.56M
193.56M
Income tax expense
50.13M
50.13M
69.36M
69.36M
Effective tax rate
21.91%
21.91%
28.48%
28.48%
Other operating expenses
106.49M
106.49M
113.08M
113.08M
Net income
156.44M
156.44M
152.93M
152.93M
Net profit margin
9.84%
9.84%
9.78%
9.78%
Earnings per share
-
-
-
-
Interest and investment income
15.44M
15.44M
60.96M
60.96M
Interest expense
-169.23M
-169.23M
-174.07M
-174.07M
Net interest expenses
-153.79M
-153.79M
-113.10M
-113.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
501.78M
501.78M
505.40M
505.40M
Gain or loss from assets sale
698.00K
698.00K
1.78M
1.78M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more